Antiatherogenic effects of β-adrenergic blocking agents: Theoretical, experimental, and epidemiologic considerations
- 31 December 1994
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 128 (6), 1316-1328
- https://doi.org/10.1016/0002-8703(94)90254-2
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: The beta-blocker heart attack trial experienceThe American Journal of Cardiology, 1990
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Decreased coronary heart disease in hypertensive smokers. Mortality results from the MAPHY study.Hypertension, 1989
- Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.Hypertension, 1989
- Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY studyJAMA, 1988
- Suppression of principal atherosclerotic mechanisms by prostacyclinc and other eicosanoidsProgress in Lipid Research, 1986
- Medical management of hyperlipidemia and the role of probucolThe American Journal of Cardiology, 1986
- Unrecognized myocardial infarction and hypertension: The Framingham StudyAmerican Heart Journal, 1985
- Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbitThe American Journal of Cardiology, 1984
- ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENTThe Lancet, 1981